pCMV-T7-EGFP (BPK1098) Citations (5)
Originally described in: CMV and T7 promoter plasmid to express EGFP (BPK1098)Unpublished
Articles Citing pCMV-T7-EGFP (BPK1098)
| Articles |
|---|
| High-efficiency of genetic modification using CRISPR/Cpf1 system for engineered CAR-T cell therapy. Ding R, Chao CC, Gao Q. Methods Cell Biol. 2022;167:1-14. doi: 10.1016/bs.mcb.2021.08.001. Epub 2021 Sep 15. PubMed |
| Programmable RNA detection with CRISPR-Cas12a. Jain P, Rananaware S, Vesco E, Shoemaker G, Anekar S, Sandoval LS, Meister K, Macaluso N, Nguyen L. Res Sq. 2023 Feb 17:rs.3.rs-2549171. doi: 10.21203/rs.3.rs-2549171/v1. Preprint. PubMed |
| Cellular fate of a plant virus immunotherapy candidate. Omole AO, Affonso de Oliveira JF, Sutorus L, Karan S, Zhao Z, Neun BW, Cedrone E, Clogston JD, Xu J, Sierk M, Chen Q, Meerzaman D, Dobrovolskaia MA, Steinmetz NF. Commun Biol. 2024 Oct 24;7(1):1382. doi: 10.1038/s42003-024-06982-0. PubMed |
| Poly(2-ethyl-2-oxazoline) (POx) as Poly(ethylene glycol) (PEG)-Lipid Substitute for Lipid Nanoparticle Formulations. Holick CT, Klein T, Mehnert C, Adermann F, Anufriev I, Streiber M, Harder L, Traeger A, Hoeppener S, Franke C, Nischang I, Schubert S, Schubert US. Small. 2025 Apr;21(16):e2411354. doi: 10.1002/smll.202411354. Epub 2025 Mar 19. PubMed |
| AsCas12a tolerates insertions in target DNA. Rananaware SR, Shoemaker GM, Pizzano BLM, Vesco EK, Sandoval LSW, Lewis JG, Bodin AP, Flannery SJ, Lange IH, Pedada D, Fang A, Antal SG, Aguilar D, Rakestraw NR, Karalkar VN, Meister KS, Nguyen LT, Jain PK. Nucleic Acids Res. 2025 Sep 5;53(17):gkaf887. doi: 10.1093/nar/gkaf887. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.